Camp4 Therapeutics Corporation · NASDAQ:CAMP
Andrew J. Schwab reported a 12.50% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)
Event Sep 9, 2025 · Filed Sep 11, 2025
Andrew J. Schwab reported a 12.50% stake in Camp4 Therapeutics Corporation, 5,869,091 shares, with active intent on Sep 9, 2025. Filed Sep 11, 2025 (Schedule 13D/A).
- Stake
- 12.50%
- Shares
- 5,869,091
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 5AM Ventures VI, L.P. | 5.60% | 2,625,145 |
| 5AM Partners VI, LLC | 5.60% | 2,625,145 |
| 5AM Ventures VII, L.P. | 6.30% | 2,941,176 |
| 5AM Partners VII, LLC | 6.30% | 2,941,176 |
| 5AM Opportunities II, L.P. | 0.60% | 302,770 |
| 5AM Opportunities II (GP), LLC | 0.60% | 302,770 |
| Andrew J. Schwab | 12.50% | 5,869,091 |
| Kush Parmar | 12.50% | 5,869,091 |
Source
Related
- Camp4 Therapeutics Corporation
- Schwab Andrew J.
- Camp4 Therapeutics Corporation shareholders
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 5, 2026
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026
- Form 4 · Tardiff Daniel · Aug 19, 2026